Reaction
Mucocutaneous Rash reporting signals
As of the last recalculation, Mucocutaneous Rash appears in 149 FAERS reports alongside 2 co-occurring drug terms. The strongest observed disproportionality signal is PANITUMUMAB (PRR 105.8).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Panitumumab | 11 | 105.8 | 105.9 |
| Vemurafenib | 4 | 47.7 | 47.8 |